Global Autogenous Vaccines Market Size, Share and Trends Analysis Report, By Type (Poultry, Fish, Pigs, and Cattle), By End-User (Livestock Farming Companies, Veterinary Research Institutes, Veterinary Clinic, and Hospitals), By Strain (Bacterial Strain and Viral Strain), Forecast (2022-2028)

The global autogenous vaccines market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Autogenous vaccines for veterinary can be defined as any immunological veterinary medicinal products which are manufactured for the purpose of producing active immunity from pathogenic organisms obtained from an animal which have the same herd that has been inactivated and used for the treatment of this animal. Autogenous vaccines are derived from pathogens. The growing focus on launching better and more effective products to prevent diseases in animals are paving the way for the growth of the market. Many animals get affected by various contagious diseases which include peste de petits ruminants (RRR) or goat plague, which is a major challenge in the animal healthcare segment.

Some major players in the market include Ceva Santé Animale, Elanco Animal Health, and Phibro Animal Health Corp., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2019, IDT Biologika, a company in the veterinary biopharmaceutical sphere, was acquired by Ceva Santé Animale (‘Ceva’). This is set to consolidate its market position in animal health products. Additionally, in October 2019, Ceva entered into a license agreement with PROBIOGEN for the manufacture of vectorized poultry vaccines using ProBioGen’s proprietary AGE1.CR technology. In August 2019, Phibro Animal Health Corp. acquired the business and assets of Osprey Biotechnics, Inc, a developer, manufacturer, and marketer of microbial products and bioproducts for a variety of animal health applications.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By End-User
  • By Strain
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Ceva Santé Animale, Elanco Animal Health, and Phibro Animal Health Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Autogenous Vaccines Market Report by Segment

By Type

• Poultry
• Fish
• Pigs and Cattle

By End-User

• Livestock Farming Companies
• Veterinary Research Institutes
• Veterinary Clinic
• Hospitals

By Strain

• Bacterial Strain
• Viral Strain

Global Autogenous Vaccines Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa